Betagenon (Sweden)

Research works: 1
Citations: 121
Top-10% rate: 0.0%
Open access: 100%
International: 45%

Betagenon (Sweden)

Not ranked overall: Betagenon (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Betagenon (Sweden) work in?

In all years, 54% of research at Betagenon (Sweden) is in Life Sciences, 46% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (54%), Medicine (46%).

Life Sciences54%Health Sciences46%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 2 fields, with their numbers

Life Sciences153.8%
1. Biochemistry, Genetics and Molecular Biology153.8%
Health Sciences146.2%
1. Medicine146.2%

All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Betagenon (Sweden)?

The most cited paper from Betagenon (Sweden) is "BMP4-BMPR1A Signaling in β Cells Is Required for and Augments Glucose-Stimulated Insulin Secretion" (Joan Goulley, Ulf Dahl, Nathalie Baeza et al., 2007), with 128 citations. Next come "PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients" (109) and "Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis" (37).

Most cited papers
#	Paper	Released	Citations
1	BMP4-BMPR1A Signaling in β Cells Is Required for and Augments Glucose-Stimulated Insulin Secretion Joan Goulley, Ulf Dahl, Nathalie Baeza et al. · Cell Metabolism Open access	Mar 2007	128
2	PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients Pär Steneberg, Emma Lindahl, Ulf Dahl et al. · JCI Insight Open access	20 Jun 2018	109
3	Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis Man K.S. Lee, Olivia D. Cooney, Xuzhu Lin et al. · Molecular Metabolism Open access	10 May 2022	37
4	Gene array identification of Ipf1/Pdx1-/-regulated genes in pancreatic progenitor cells Per Svensson, Cecilia Williams, Joakim Lundeberg et al. · BMC Developmental Biology Open access	23 Nov 2007	29

All 4 most cited papers, with filters and sorting

Which research topics does Betagenon (Sweden) publish most on?

By volume in 2022-now: Sphingolipid Metabolism and Signaling, Cancer, Lipids, and Metabolism and Cholesterol and Lipid Metabolism.

1 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
2 Cancer, Lipids, and Metabolism Cancer Research 0 works
3 Cholesterol and Lipid Metabolism Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

100%

openly available100.0%

World: 40% of research is openly available.

45%55%

with international co-authors44.9%domestic only55.1%

World: 18% is written across borders.

How has Betagenon (Sweden)'s research output changed?

Output in 2022-2025 was 78% lower than in 2018-2021.

Other research institutions in Umeå

All research institutions in Umeå

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Betagenon (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.